Unknown OBSERVATIONAL NCT05851079

Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions

Sponsor: Tongji Hospital

Conditions Cervical Intraepithelial Neoplasia Grade 2/3 Cervical Lesion

Interventions Cobas HPV test High throughput HPV typing and integration detection methods TCT test Vaginoscopy

Updated 4 times since 2023 Last updated: May 5, 2023 Started: Dec 10, 2021 Primary completion: Nov 30, 2024 Completion: Nov 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05851079, this observational or N/A phase trial focuses on Cervical Intraepithelial Neoplasia Grade 2/3 and Cervical Lesion and remains ongoing. Sponsored by Tongji Hospital, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Jun 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Jun 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tongji Hospital
Women's Hospital School Of Medicine Zhejiang University
Wuhan Central Hospital

Data source: Women's Hospital School Of Medicine Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China